𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A randomized comparison of melphalan versus melphalan plus hexamethylmelamine versus adriamycin plus cyclophosphamide in ovarian carcinoma

✍ Scribed by G. A. Omura; C. P. Morrow; J. A. Blessing; A. Miller; H. J. Buchsbaum; H. D. Homesley; L. Leone

Publisher
John Wiley and Sons
Year
1983
Tongue
English
Weight
590 KB
Volume
51
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Treatment of chronic lymphocytic leukemi
Treatment of chronic lymphocytic leukemia in advanced stages. A randomized trial comparing chlorambucil plus prednisone versus cyclophosphamide, vincristine, and prednisone
✍ Emilio Montserrat; Antonio AlcalΓ‘; Ricardo Parody; Andreu Domingo; Javier GarcΓ­a πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 685 KB

Ninety-six patients with advanced chronic lymphocytic leukemia (CLL) (Stage C; anemia and/or thrombocytopenia of nonimmune origin) were randomized to receive either chlorambucil (CLR) (0.4 mg/kg orally, day 6) plus prednime (PDN) (60 mg/m2 orally, days 1-5) every 2 weeks or cyclophosphamide (600 mg/

A Phase I trial of intravenous melphalan
A Phase I trial of intravenous melphalan, paclitaxel, and cisplatin plus granulocyte-colony stimulating factor in patients with suboptimal advanced epithelial ovarian carcinoma or peritoneal carcinoma
✍ David M. Gershenson; Mitchell Morris; Thomas W. Burke; Charles Levenback; Judith πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 96 KB πŸ‘ 2 views

The primary purpose of this study was to establish the maximum tolerated dose (MTD) of intravenous melphalan in combination with paclitaxel and cisplatin plus granulocyte-colony stimulating factor (G-CSF) in patients with suboptimal advanced epithelial ovarian carcinoma or primary peritoneal carcino